Table 2.
Compendium of gold standards for the treatment of diabetic complications
Complication types | Gold standard | Indication | Mechanism | Effect | Side effects | References |
---|---|---|---|---|---|---|
Diabetic retinopathy | Anti-VEGF therapy | Proliferative diabetic retinopathy, diabetic macular edema | Inhibits VEGF, reducing neovascularization and macular edema | Reduces vision loss, improves visual acuity | Eye pain, intraocular inflammation, vitreous hemorrhage | [75] |
Laser photocoagulation | Proliferative diabetic retinopathy, severe non-proliferative diabetic retinopathy | Destroys ischemic retinal tissue to prevent neovascularization | Stabilizes retinal structure, prevents vision loss | Eye pain, peripheral vision loss, scarring | [76] | |
Diabetic nephropathy | Angiotensin converting enzyme inhibitors (ACE inhibitors) | Proteinuria, hypertension | Inhibits angiotensin-converting enzyme, reducing blood pressure and proteinuria | Reduce blood pressure, protects renal function | Hyperkalemia, cough, angioedema | [77] |
Angiotensin receptor blockers (ARBs) | Proteinuria, hypertension | Blocks angiotensin II receptors, reducing blood pressure and proteinuria | Reduce blood pressure, protects renal function | Hyperkalemia, dizziness, kidney dysfunction | [78] | |
Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors) | Proteinuria, early diabetic nephropathy | Reduces glucose reabsorption in kidneys, reducing blood sugar and improving renal outcomes | Reduce blood glucose, reduces proteinuria | Genital infections, dehydration, ketoacidosis | [79] | |
Diabetic neuropathy | Antidepressants | Peripheral neuropathy, pain | Inhibits serotonin and norepinephrine reuptake, modulating pain pathways | Reduces neuropathic pain, improves quality of life | Drowsiness, dizziness, nausea | [80] |
Anticonvulsants | Peripheral neuropathy, pain | Modulates calcium channel function, reducing neuronal excitability | Reduces neuropathic pain, improves sleep quality | Dizziness, weight gain, peripheral edema | [81] | |
Diabetic foot | Debridement | Ulcers, necrotic tissue | Removes necrotic tissue, promotes wound healing | Enhances wound healing, prevents infection | Pain, bleeding, infection | [82] |
Antibiotics | Infected ulcers, soft tissue infections | Eliminates bacterial infection, reducing inflammation | Resolves infection, prevents spread | Antibiotic resistance, gastrointestinal upset | [83] | |
Offloading devices | Pressure ulcers | Redistributes pressure away from ulcers, reducing mechanical stress | Promotes ulcer healing, prevents new ulcers | Discomfort, skin irritation | [84] | |
Diabetic cardiovascular disease | Statins | Hyperlipidemia, atherosclerosis | Inhibits HMG-CoA reductase, reducing cholesterol levels | Reduce low density lipoprotein cholesterol, reduces cardiovascular risk | Muscle pain, liver enzyme elevation | [85] |
Beta-blockers | Hypertension, heart failure | Blocks β-adrenergic receptors, reducing heart rate and blood pressure | Reduce blood pressure, reduces heart failure symptoms | Fatigue, bradycardia, hypotension | [86] | |
ACE inhibitors | Hypertension, heart failure | Inhibits angiotensin-converting enzyme, reducing blood pressure and myocardial workload | Reduce blood pressure, improves heart function | Hyperkalemia, cough, angioedema | [87] |